Fisher Daniel W, Dunn Jeffrey T, Dong Hongxin
Department of Psychiatry and Behavioral Sciences, Northwestern University Feinberg School of Medicine, 303 E Chicago Ave, Chicago, IL, 60611, USA.
Department of Psychiatry and Behavioral Sciences, University of Washington School of Medicine, 1959 NE Pacific Street, Box 356560, Seattle, WA, 98195, USA.
Discov Ment Health. 2024 Jan 4;4(1):3. doi: 10.1007/s44192-023-00057-y.
Depression is a common and devastating neuropsychiatric symptom in the elderly and in patients with dementia. In particular, nearly 80% of patients with Alzheimer's Disease dementia experience depression during disease development and progression. However, it is unknown whether the depression in patients with dementia shares the same molecular mechanisms as depression presenting as primary psychiatric disease or occurs and persists through alternative mechanisms. In this review, we discuss how the clinical presentation and treatment differ between depression in dementia and as a primary psychiatric disease, with a focus on major depressive disorder. Then, we hypothesize several molecular mechanisms that may be unique to depression in dementia such as neuropathological changes, inflammation, and vascular events. Finally, we discuss existing issues and future directions for investigation and treatment of depression in dementia.
抑郁症是老年人及痴呆症患者中常见且具有破坏性的神经精神症状。特别是,近80%的阿尔茨海默病痴呆症患者在疾病发展和进展过程中会出现抑郁症。然而,尚不清楚痴呆症患者的抑郁症是否与原发性精神疾病所致抑郁症具有相同的分子机制,或者是否通过其他机制发生并持续存在。在这篇综述中,我们讨论了痴呆症相关抑郁症与原发性精神疾病所致抑郁症在临床表现和治疗方面的差异,重点关注重度抑郁症。然后,我们推测了几种可能是痴呆症相关抑郁症所特有的分子机制,如神经病理变化、炎症和血管事件。最后,我们讨论了痴呆症相关抑郁症研究和治疗中存在的问题及未来方向。